USAC Board of Directors

Gary C. Evans

Chairman of the Board

Gary C. Evans is a serial entrepreneur. Throughout his career, he has taken three separate energy companies public on the NYSE. At present, he serves as Chairman of the Board, Chief Executive Officer, and is the largest shareholder of Evergreen Sustainable Enterprises, Inc. ("Evergreen") Mr. Evans launched Evergreen as an evolution from his hemp company, Generation Hemp, Inc, while developing diversified green energy plants designed to use hemp biomass as biofuel to generate power to mine Bitcoin. Throughout his career, Mr. Evans has raised various forms of capital on Wall Street that have exceeded $7 Billion. Mr. Evans has previously served for 24 years as a Director of Novavax Inc., a NASDAQ listed (“NVAX”) clinical-stage vaccine biotechnology company (Covid-19 Vaccine) which achieved a market capitalization in excess of $18 Billion during the pandemic, where he also previously served as Chairman, CEO and Lead Director.

email: gevans@usantimony.com

Blaise A. Aguirre

Blaise A. Aguirre, MD: Dr. Aguirre joined the Board of Directors of United States Antimony Corp. on August 14 2019, to replace a Director that retired for medical reasons. He received his Medical Doctor’s degree in 1989 from the University of the Witwatersrand, Johannesburg, South Africa, and performed his residency at Boston University School of Medicine from 1991 to 1994. He is an Assistant Professor of Psychiatry at Harvard Medical School and he is the founding Medical Director of 3East at McLean Hospital. Blaise is fluent in Spanish and lectures worldwide. He was elected to the Board at Investors Capital Holdings, Ltd in 2011 and remained on the Board until it was sold to RCAP.  He sits on the boards of various privately held companies. He developed and maintains enduring relationships with institutional money managers, venture capitalists, Angel investors and developed an expertise as a small cap stock analyst as a broker with series 7 and 63 securities licenses.

Joe Bardswich

Lloyd Joseph Bardswich joined the board of directors of United States Antimony Corp. on February 9, 2021. Joe has extensive experience in mining, mining engineering, management, drilling, metallurgy and plant design. He is a registered professional mining engineer, can served as a QP (qualified person) regarding reporting to NI43-101 standards and has worked as a Shift Boss, Mine Safety Engineer, Mine Foreman, Mine Manager, and Mining Consultant. It has not yet been determined which committees of the Board on which Mr. Bardswich will serve.

Michael A. McManus

Michael McManus is a recognized leader and builder of enterprises with successes as a public company CEO, senior government experience, a lawyer, new product development leader, and has served on the board of several companies. Mr. McManus served as a board member for Novavax, a biotechnology company committed to help address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world. Mr. McManus has previously served as president, chief executive officer, and director at Misonix, Inc., a medical, scientific, and industrial provider of ultrasonic and air pollution systems, since 1998. Prior to that tenure, he was president and chief executive officer at New York Bancorp Inc. from 1991 to 1998. From 1990 through November 1991, Mr. McManus was president and chief executive officer at Jamcor Pharmaceuticals Inc. Previously, Mr. McManus served as an assistant to the President of the United States from 1982 to 1985 and held positions with Pfizer Inc. and Revlon Group. Mr. McManus received a BA in economics from the University of Notre Dame and a JD from the Georgetown University Law Center. He served in the US Army Infantry from 1968 through 1970. He is also a recipient of the Ellis Island Medal of Honor. 

Joseph A. Carrabba

Mr. Carrabba is the Retired Chairman, President and Chief Executive Officer of Cliffs Natural Resources, Inc., formerly Cleveland-Cliffs, Inc., from May 2007 to November 2013. He also previously served as Cliffs President & CEO from 2006 to 2007 and as President and Chief Operating Officer from 2005 to 2006. Prior to these executive positions, Mr. Carrabba previously served as President and Chief Operating Officer of Diavik Diamond Mines from 2003 to 2006.

Mr. Carrabba currently resides in south Florida and serves or has previously served on the boards of several other NYSE listed companies including Newmont Mining and Timken Steel, as well as several TSX listed companies, AECON and NioCorp.

Fred L. “Pete” Bunger 

Pete was welcomed to the board and management team of USAC and BRZ as the Technical Advisory Director in 2024. Pete is the founder and President of ZEO, Inc. since 1982. His company is one of the largest customers of Bear River Zeolite, our wholly-owned subsidiary active in zeolite mining and processing in Idaho. His company is involved in product development and marketing of natural zeolites and allied products to both domestic and international wholesale markets. ZEO, Inc. products have applications in water filtration, animal feed, soil amendment, and specialty products. Mr. Bunger previously held various positions and was General Manager at Occidental Petroleum from 1978 until 1982, when he started his own company. He was also previously employed at DuPont from 1967-1978 in various R&D activities. Mr. Bunger received his B.S. in Chemistry, Physics, and Math in 1963 from Austin Peay State University. He subsequently received his Ph.D. in 1967 from the University of North Carolina. His major was Inorganic Chemistry with a minor in Analytical Chemistry.